Trials / Unknown
UnknownNCT00423306
A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Alaunos Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study of safety of a new organic arsenic compound in the treatment of advanced hepatocellular carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Darinaparsin | 420 mg/m2 of Darinaparsin given twice weekly for three weeks, followed by one week of rest, for up to 6 months |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2007-01-18
- Last updated
- 2013-11-14
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00423306. Inclusion in this directory is not an endorsement.